Neoadjuvant Therapy is Associated with Improved Survival in Borderline-Resectable Pancreatic Cancer

Background Neoadjuvant therapy has shown value in various cancer types. The role of neoadjuvant therapy in pancreatic ductal adenocarcinoma (PDAC), however, remains unknown. The aim of the present work is to evaluate the effect of neoadjuvant therapy on the survival of patients with borderline-resec...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Annals of surgical oncology 2020-04, Vol.27 (4), p.1191-1200
Hauptverfasser:	Chawla, Akhil, Molina, George, Pak, Linda M., Rosenthal, Michael, Mancias, Joseph D., Clancy, Thomas E., Wolpin, Brian M., Wang, Jiping
Format:	Artikel
Sprache:	eng
Schlagworte:	Adenocarcinoma Aged Biopsy Carcinoma, Pancreatic Ductal - pathology Carcinoma, Pancreatic Ductal - therapy Combined Modality Therapy Databases, Factual Female Humans Male Medicine Medicine & Public Health Middle Aged Neoadjuvant Therapy - mortality Oncology Pancreatectomy - mortality Pancreatic cancer Pancreatic Neoplasms - pathology Pancreatic Neoplasms - therapy Pancreatic Tumors Retrospective Studies Surgery Surgical Oncology Survival Survival Analysis Treatment Outcome United States - epidemiology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!